Yannis Badri, Antoine Levron, Emilie Agard, Charles-Henry Remignon, Roman Chudzinski, Jeremy Billant, Hugo Bouvarel, Pierre Leroux, Ines Fenniri, Pierre Pradat, Corinne Dot
{"title":"评估常规角膜散光患者植入高倍散光眼内透镜后的屈光效果。","authors":"Yannis Badri, Antoine Levron, Emilie Agard, Charles-Henry Remignon, Roman Chudzinski, Jeremy Billant, Hugo Bouvarel, Pierre Leroux, Ines Fenniri, Pierre Pradat, Corinne Dot","doi":"10.1007/s00417-024-06586-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To describe the refractive outcomes of eyes with high regular corneal astigmatism undergoing age-related cataract surgery.</p><p><strong>Methods: </strong>Astigmatic patients who underwent cataract surgery with implantation of high-power XY1AT HOYA<sup>®</sup> toric lenses (IOLs) (≥ T5) between March 2020 and June 2022 were included. Patients were divided into 2 groups based on the type of Total Corneal Astigmatism (TCA) used for the toric IOL calculation: group 1 = TCA<sup>TK- 700</sup> (TCA measured by the Iol Master 700<sup>®</sup>) and group 2 = TCA<sup>AK- 700</sup> (TCA estimated from the anterior keratometry of the Iol Master 700<sup>®</sup> and using the Abulafia-Koch regression). The best-uncorrected (UDVA) and corrected (CDVA) distance visual acuity, subjective spherical equivalent (SSEq) and subjective residual cylinder (SRC) were assessed at 1 month. The predictability (centroid [CEPA] and mean absolute error in predicted astigmatism [MAEPA]) of the 2 TCA assessment methods was analyzed.</p><p><strong>Results: </strong>96 eyes of 74 patients were included. In the whole cohort, the UDVA was 0.14 ± 0.19 logMAR, the CDVA was 0.04 ± 0.07 logMAR. Postoperative SSEq was - 0.24 ± 0.53D. Postoperative SRC was - 0.48 ± 0.56D. The UDVA, SSEq and SRC did not significantly differ between groups. The MAEPA was significantly better with TCA<sup>AK-700</sup> compared to TCA<sup>TK-700</sup>: 0.58 ± 0.52D versus 0.65 ± 0.55D (p = 0.01). No significant difference was observed for the CEPA (p(x) = 0.09, p(y) = 0.19).</p><p><strong>Conclusions: </strong>XY1AT HOYA<sup>®</sup> toric IOLs are a very good alternative even in case of high toricity. Residual astigmatism predictability is high, it would be better with TCA<sup>AK- 700</sup>. This data should be confirmed with a larger sample of patients.</p>","PeriodicalId":12795,"journal":{"name":"Graefe’s Archive for Clinical and Experimental Ophthalmology","volume":" ","pages":"3915-3923"},"PeriodicalIF":2.4000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Assessment of the refractive outcomes of patients with regular corneal astigmatism implanted with high-power toric intraocular lenses.\",\"authors\":\"Yannis Badri, Antoine Levron, Emilie Agard, Charles-Henry Remignon, Roman Chudzinski, Jeremy Billant, Hugo Bouvarel, Pierre Leroux, Ines Fenniri, Pierre Pradat, Corinne Dot\",\"doi\":\"10.1007/s00417-024-06586-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>To describe the refractive outcomes of eyes with high regular corneal astigmatism undergoing age-related cataract surgery.</p><p><strong>Methods: </strong>Astigmatic patients who underwent cataract surgery with implantation of high-power XY1AT HOYA<sup>®</sup> toric lenses (IOLs) (≥ T5) between March 2020 and June 2022 were included. Patients were divided into 2 groups based on the type of Total Corneal Astigmatism (TCA) used for the toric IOL calculation: group 1 = TCA<sup>TK- 700</sup> (TCA measured by the Iol Master 700<sup>®</sup>) and group 2 = TCA<sup>AK- 700</sup> (TCA estimated from the anterior keratometry of the Iol Master 700<sup>®</sup> and using the Abulafia-Koch regression). The best-uncorrected (UDVA) and corrected (CDVA) distance visual acuity, subjective spherical equivalent (SSEq) and subjective residual cylinder (SRC) were assessed at 1 month. The predictability (centroid [CEPA] and mean absolute error in predicted astigmatism [MAEPA]) of the 2 TCA assessment methods was analyzed.</p><p><strong>Results: </strong>96 eyes of 74 patients were included. In the whole cohort, the UDVA was 0.14 ± 0.19 logMAR, the CDVA was 0.04 ± 0.07 logMAR. Postoperative SSEq was - 0.24 ± 0.53D. Postoperative SRC was - 0.48 ± 0.56D. The UDVA, SSEq and SRC did not significantly differ between groups. The MAEPA was significantly better with TCA<sup>AK-700</sup> compared to TCA<sup>TK-700</sup>: 0.58 ± 0.52D versus 0.65 ± 0.55D (p = 0.01). No significant difference was observed for the CEPA (p(x) = 0.09, p(y) = 0.19).</p><p><strong>Conclusions: </strong>XY1AT HOYA<sup>®</sup> toric IOLs are a very good alternative even in case of high toricity. Residual astigmatism predictability is high, it would be better with TCA<sup>AK- 700</sup>. This data should be confirmed with a larger sample of patients.</p>\",\"PeriodicalId\":12795,\"journal\":{\"name\":\"Graefe’s Archive for Clinical and Experimental Ophthalmology\",\"volume\":\" \",\"pages\":\"3915-3923\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Graefe’s Archive for Clinical and Experimental Ophthalmology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00417-024-06586-8\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/7/26 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Graefe’s Archive for Clinical and Experimental Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00417-024-06586-8","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/26 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
Assessment of the refractive outcomes of patients with regular corneal astigmatism implanted with high-power toric intraocular lenses.
Background: To describe the refractive outcomes of eyes with high regular corneal astigmatism undergoing age-related cataract surgery.
Methods: Astigmatic patients who underwent cataract surgery with implantation of high-power XY1AT HOYA® toric lenses (IOLs) (≥ T5) between March 2020 and June 2022 were included. Patients were divided into 2 groups based on the type of Total Corneal Astigmatism (TCA) used for the toric IOL calculation: group 1 = TCATK- 700 (TCA measured by the Iol Master 700®) and group 2 = TCAAK- 700 (TCA estimated from the anterior keratometry of the Iol Master 700® and using the Abulafia-Koch regression). The best-uncorrected (UDVA) and corrected (CDVA) distance visual acuity, subjective spherical equivalent (SSEq) and subjective residual cylinder (SRC) were assessed at 1 month. The predictability (centroid [CEPA] and mean absolute error in predicted astigmatism [MAEPA]) of the 2 TCA assessment methods was analyzed.
Results: 96 eyes of 74 patients were included. In the whole cohort, the UDVA was 0.14 ± 0.19 logMAR, the CDVA was 0.04 ± 0.07 logMAR. Postoperative SSEq was - 0.24 ± 0.53D. Postoperative SRC was - 0.48 ± 0.56D. The UDVA, SSEq and SRC did not significantly differ between groups. The MAEPA was significantly better with TCAAK-700 compared to TCATK-700: 0.58 ± 0.52D versus 0.65 ± 0.55D (p = 0.01). No significant difference was observed for the CEPA (p(x) = 0.09, p(y) = 0.19).
Conclusions: XY1AT HOYA® toric IOLs are a very good alternative even in case of high toricity. Residual astigmatism predictability is high, it would be better with TCAAK- 700. This data should be confirmed with a larger sample of patients.
期刊介绍：
Graefe''s Archive for Clinical and Experimental Ophthalmology is a distinguished international journal that presents original clinical reports and clini-cally relevant experimental studies. Founded in 1854 by Albrecht von Graefe to serve as a source of useful clinical information and a stimulus for discussion, the journal has published articles by leading ophthalmologists and vision research scientists for more than a century. With peer review by an international Editorial Board and prompt English-language publication, Graefe''s Archive provides rapid dissemination of clinical and clinically related experimental information.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
